Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Endometrial Neoplasms 2

Interventions

Specimen Handling 122pembrolizumab 118Magnetic Resonance Spectroscopy 107Carboplatin 86Cyclophosphamide 75Biopsy 68Cisplatin 63Paclitaxel 58Bevacizumab 56Gemcitabine 49Nivolumab 47fludarabine 44Dexamethasone 39Rituximab 38Pemetrexed 38Fluorouracil 37atezolizumab 36Docetaxel 36Doxorubicin 34Radiotherapy 33Leucovorin 33venetoclax 31Oxaliplatin 30Capecitabine 30Temozolomide 28Prednisone 28Standard of Care 27Radiation 27Letrozole 27Cetuximab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Megestrol Acetate × 30 days × Clear all
NCT05247268 2026-06-04

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Fudan University

Phase 2 Recruiting
104 enrolled
Gynecologic

Endometrial Neoplasms

NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting
1,615 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡